The lights dimmed as five actors took their places around a table on a makeshift stage in a New York City art gallery turned ...
OpenAI chief Sam Altman on Friday said his high-profile artificial intelligence company is “on the wrong side of history” ...
Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT ...
OpenAI chief executive Sam Altman, who provided the initial $180mn ... which it says can reverse their ageing process. The San Francisco-based biotech will use the money to fund clinical trials ...
SAN FRANCISCO (KRON) — President Donald Trump stood with one of San Francisco’s top tech tycoons inside the White House on Tuesday to announce a $500 billion artificial intelligence project ...